Picture of Zynerba Pharmaceuticals logo

ZYNE — Zynerba Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall Cap

Brief: Zynerba Pharmaceuticals Reports First Quarter 2022 Financial Results And Operational Highlights

Zynerba Pharmaceuticals Inc  ZYNE.O :
    * ZYNERBA PHARMACEUTICALS REPORTS FIRST QUARTER 2022
FINANCIAL
RESULTS AND OPERATIONAL HIGHLIGHTS
    * Q1 LOSS PER SHARE $0.21
    * AS OF MARCH 31, 2022, CASH AND CASH EQUIVALENTS WERE $69.7
MILLION, COMPARED TO $67.8 MILLION AS OF DECEMBER 31, 2021
    * Q1 EARNINGS PER SHARE VIEW $-0.23 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX5FTHw7 
Further company coverage:  ZYNE.O

Recent news on Zynerba Pharmaceuticals

See all news